SciSparc Ltd. (SPRC) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$1.66

From 52W high−96.29%

Volume205370.00

Market cap$836601.12

P/E (TTM)—

P/S (TTM)1.2x

Div yield—

Key dataOct 19, 2026

Open

$1.66

From 52W high

−96.29%

Volume

205370.00

Market cap

$836601.12

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.5x

P/E (TTM)

—

RSI (14)

17.5

MomentumView details →

1D Return

−15.29%

YTD Return

−86.52%

SummaryUpdated Jun 1, 2026

SciSparc Ltd. (NASDAQ:SPRC) is a specialty clinical-stage pharmaceutical company founded in 2004 and headquartered in Tel Aviv-Yafo, Israel. Originally incorporated as Therapix Biosciences Ltd., the company rebranded to SciSparc in January 2021 and went public on NASDAQ in August 2021. The company focuses on developing therapeutic drugs based on cannabinoid molecules, targeting various neurological and psychiatric conditions through its pipeline of investigational treatments.

Ask drillr about SciSparc Ltd. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.5x

EV/Sales

9.4x

P/S (TTM)

1.2x

P/B (TTM)

0.2x

ProfitabilityView details →

Gross Margin

64.51%

Net Margin

−1210.90%

EBITDA Margin

−640.65%

ROE (TTM)

−208.42%

ROA (TTM)

−44.46%

Asset Turnover

0.05x

GrowthView details →

Revenue YoY

−26.75%

EPS YoY

+54.05%

FCF YoY

−22.45%

Revenue CAGR 3Y

−14.03%

EPS CAGR 3Y

—

EBITDA YoY

+65.55%

MomentumView details →

1D Return

−15.29%

YTD Return

−86.52%

1Y Return

−95.75%

RSI (14)

17.5

vs 50D SMA

−68.20%

vs 200D SMA

−73.00%

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

0.87x

Quick Ratio

0.86x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.40

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.61M

Net Income (TTM)

−20.39M

Op. CF (TTM)

−10.61M

Latest newsMore news →

SciSparc Ltd. shares were halted on a downside circuit breaker after falling 23.69%.4d ago

SciSparc announced that it will shift its strategic focus toward agentic AI-powered technologies, including cybersecurity and finance technologies.5d ago

Similar companies

IO Biotech, Inc.IOBT NKGen Biotech, Inc. WarrantsNKGNW Voyager Acquisition CorpVRXAW BNB Plus Corp.BNBX Curis, Inc.CRIS Propanc Biopharma, Inc.PPCB Find similar companies →

Latest newsMore news →

SciSparc Ltd. shares were halted on a downside circuit breaker after falling 23.69%.4d ago SciSparc announced that it will shift its strategic focus toward agentic AI-powered technologies, including cybersecurity and finance technologies.5d ago